Importance of food effects for oral oncology drugs.
作者信息
Ratain Mark J
机构信息
The University of Chicago, Chicago, Illinois, USA.
出版信息
Clin Adv Hematol Oncol. 2012 Jun;10(6):397-8.
PMID:22895243
Abstract
摘要
相似文献
1
Importance of food effects for oral oncology drugs.食物对口腔肿瘤学药物的影响的重要性。
Clin Adv Hematol Oncol. 2012 Jun;10(6):397-8.
2
Flushing oral oncology drugs down the toilet.将口腔肿瘤药物冲进马桶。
J Clin Oncol. 2011 Oct 20;29(30):3958-9. doi: 10.1200/JCO.2011.37.1617. Epub 2011 Sep 19.
3
Abiraterone acetate is well tolerated without concomitant use of corticosteroids.醋酸阿比特龙在不联合使用皮质类固醇的情况下耐受性良好。
J Clin Oncol. 2010 Oct 10;28(29):e560-1; author reply e562. doi: 10.1200/JCO.2010.29.5170. Epub 2010 Aug 30.
4
Food effects on oral agents.食物对口服制剂的影响。
Clin Adv Hematol Oncol. 2007 Aug;5(8):589-90.
5
[Oral bioavailability of oncological preparations: the intake conditions are often decisive].
Urologe A. 2014 Dec;53(12):1772-8. doi: 10.1007/s00120-014-3644-8.
6
The role of abiraterone in the management of metastatic castration-resistant prostate cancer.阿比特龙在转移性去势抵抗性前列腺癌治疗中的作用。
Expert Rev Anticancer Ther. 2012 Apr;12(4):429-37. doi: 10.1586/era.12.12.
7
Food and oral antineoplastics: more than meets the eye.口服抗肿瘤药物与食物：比想象中更复杂。
Clin Cancer Res. 2010 Sep 1;16(17):4305-7. doi: 10.1158/1078-0432.CCR-10-1857. Epub 2010 Aug 24.
8
Cancer expert doubts claims about prostate cancer trial.
BMJ. 2008 Jul 24;337:a979. doi: 10.1136/bmj.a979.
9
Prostate cancer: score one for validated targets.前列腺癌：已验证靶点得一分。
Clin Cancer Res. 2011 Jun 15;17(12):3866. doi: 10.1158/1078-0432.CCR-11-1175.
10
Cytotoxicity and metabolism of E-DES-diphosphate.
Prog Clin Biol Res. 1989;303:187-95.
引用本文的文献
1
Food Effect on the Pharmacokinetics of VC004, a Tropomyosin Receptor Kinase Inhibitor: A Randomized Crossover Trial in Healthy Chinese Subjects.食物对原肌球蛋白受体激酶抑制剂VC004药代动力学的影响：一项在中国健康受试者中进行的随机交叉试验
Clin Drug Investig. 2024 Jan;44(1):79-85. doi: 10.1007/s40261-023-01334-y. Epub 2023 Dec 19.
2
Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.美国食品药品监督管理局对2011 - 2017年批准的肿瘤学新分子实体的反向翻译：抗癌药物开发的经验教训
Clin Transl Sci. 2018 Mar;11(2):123-146. doi: 10.1111/cts.12527. Epub 2017 Dec 19.
Zotero 插件